Business News • PR NewsWire • Merrimack to Present Pre-Clinical Data on MM-121 and MM-111 at the 101st Annual Meeting of the American Association for Cancer Research (AACR)

Merrimack to Present Pre-Clinical Data on MM-121 and MM-111 at the 101st Annual Meeting of the American Association for Cancer Research (AACR)

Merrimack to Present Pre-Clinical Data on MM-121 and MM-111 at the 101st Annual Meeting of the American Association for Cancer Research (AACR)

CAMBRIDGE, Mass., April 17 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. announced today that it will present pre-clinical data on MM-121 and MM-111, the two lead candidates in the company's pipeline of five novel cancer antibodies, at the 101st Annual Meeting of the American Association for Cance

View More : http://www.prnewswire.com/news-releases/merrimack-to-present-pre-clinical-data-on-mm-121-and-mm-111-at-the-101st-annual-...

Releted News by prnewswire

Americans Back Space Exploration, Know Little About Proposed Policy Changes, Everett Group 'Space Poll' Finds

Six Nobel Laureates, Connected with Scholars for Peace in the Middle East, and Elie Wiesel Counter Desmond Tutu and Noam Chomsky's Statements on Israel Divestment Issue at UC Berkeley

New Jenn-Air(R) Pro-Style(R) Range Collection Features Advanced LCD Screen for Enhanced Usability

Yongye International, Inc. Sees Bright Future Ahead for China's Agriculture Industry

KitchenAid Expands Cooktop Collection With New Downdraft Models